HBI-3000

HBI-3000 · HUYABIO International, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HBI-3000, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF) [Phase 2]